Clinical pharmacology of artemisinin-based combination therapies

Clinical Pharmacokinetics
Polina I German, Francesca T Aweeka

Abstract

Malaria, a disease transmitted by the female Anopheles mosquito, has had devastating effects on human populations for more than 4000 years. Treatment of the disease with single drugs, such as chloroquine, sulfadoxine/pyrimethamine or mefloquine, has led to the emergence of resistant Plasmodium falciparum parasites that lead to the most severe form of the illness. Artemisinin-based combination therapies are currently recommended by WHO for the treatment of uncomplicated P. falciparum malaria. Artemisinin and semisynthetic derivatives, including artesunate, artemether and dihydroartemisinin, are short-acting antimalarial agents that kill parasites more rapidly than conventional antimalarials, and are active against both the sexual and asexual stages of the parasite cycle. Artemisinin fever clearance time is shortened to 32 hours as compared with 2-3 days with older agents. To delay or prevent emergence of resistance, artemisinins are combined with one of several longer-acting drugs--amodiaquine, mefloquine, sulfadoxine/pyrimethamine or lumefantrine--which permit elimination of the residual malarial parasites. The clinical pharmacology of artemisinin-based combination therapies is highly complex. The short-acting artemisinins and ...Continue Reading

References

Nov 1, 1992·The Journal of Antimicrobial Chemotherapy·N J White
Apr 1, 1992·Biochemical Pharmacology·A C HarrisonB K Park
Jan 1, 1987·European Journal of Clinical Pharmacology·P A WinstanleyA M Breckenridge
Jan 1, 1987·British Journal of Clinical Pharmacology·P WinstanleyA Breckenridge
Jan 5, 1974·British Medical Journal·M Briggs, M Briggs
Feb 1, 1995·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·H JewellB K Park
Jan 1, 1994·Fundamental & Clinical Pharmacology·J Karbwang, K Na-Bangchang
Jan 1, 1994·European Journal of Clinical Pharmacology·C MartinR Farinotti
Jul 19, 1994·Proceedings of the National Academy of Sciences of the United States of America·T Triglia, A F Cowman
Apr 1, 1996·Clinical Pharmacokinetics·S Krishna, N J White
Jan 1, 1997·The American Journal of Tropical Medicine and Hygiene·J S Sidhu, M Ashton
Jan 1, 1997·The American Journal of Tropical Medicine and Hygiene·A BenakisS T Plessas
Jun 1, 1994·Journal of Pharmaceutical Sciences·F GimenezR Farinotti
Jan 1, 1997·European Journal of Clinical Pharmacology·C CrevoisierC Kleinbloesem
Aug 27, 1998·Pharmacology & Therapeutics·M Foley, L Tilley
Sep 5, 1998·Clinical Pharmacology and Therapeutics·U S SvenssonD C Le
Dec 8, 1998·European Journal of Drug Metabolism and Pharmacokinetics·M A van AgtmaelC J van Boxtel
Jan 30, 1999·Antimicrobial Agents and Chemotherapy·R PriceN J White
Jun 4, 1999·Trends in Pharmacological Sciences·M A van AgtmaelC J van Boxtel
Aug 24, 1999·European Journal of Clinical Pharmacology·M A van AgtmaelC J van Boxtel
Sep 24, 1999·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·D ColussiG Lefèvre
Dec 1, 1999·Clinical Pharmacology and Therapeutics·J A SimpsonN J White
Mar 23, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·G LefèvreM S Thomsen
Nov 25, 2000·The Journal of Pharmacy and Pharmacology·W RidtitidM Sunbhanich
Mar 17, 2001·The Journal of Antimicrobial Chemotherapy·F BarchiesiM A Viviani
Jun 23, 2001·Journal of Chromatography. B, Biomedical Sciences and Applications·S I BhoirM Sundaresan
Jun 26, 2001·British Journal of Clinical Pharmacology·Y KhaliqA McCarthy
Jul 4, 2001·Clinical Pharmacokinetics·P T Giao, P J de Vries
Dec 26, 2001·Antimicrobial Agents and Chemotherapy·Nehal VyasChristy M Wyandt
Jan 5, 2002·Trends in Parasitology·C H SibleyA M Nzila
Jan 24, 2002·The Journal of Pharmacology and Experimental Therapeutics·Xue-Qing LiCollen M Masimirembwa
Aug 9, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Kenneth F IlettGeoffrey Edwards

❮ Previous
Next ❯

Citations

Jun 17, 2010·European Journal of Clinical Pharmacology·Kazeem A OshikoyaImti Choonara
Apr 4, 2009·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Alberto MartínezRoberto A Sánchez-Delgado
Feb 22, 2011·Apoptosis : an International Journal on Programmed Cell Death·Ning GaoXianglin Shi
Nov 3, 2009·Nature Reviews. Microbiology·Richard T Eastman, David A Fidock
Jun 29, 2011·Proceedings of the National Academy of Sciences of the United States of America·Nectarios KlonisLeann Tilley
Feb 23, 2013·Proceedings of the National Academy of Sciences of the United States of America·Nectarios KlonisLeann Tilley
Aug 21, 2008·The Journal of Antimicrobial Chemotherapy·Marta SousaMarta Boffito
Feb 10, 2012·The Journal of Antimicrobial Chemotherapy·Pauline Byakika-KibwikaConcepta Merry
Jul 5, 2012·The Journal of Antimicrobial Chemotherapy·Alexis NzilaAssad Al-Thukair
Feb 15, 2012·Antimicrobial Agents and Chemotherapy·Kevin T BattyTimothy M E Davis
Mar 18, 2009·Pharmacogenomics·Rajeev K MehlotraPeter A Zimmerman
Oct 26, 2013·Clinical Pharmacokinetics·Tony K L KiangMary H H Ensom
Apr 30, 2014·The Journal of Antimicrobial Chemotherapy·Kashyap PatelCarl M Kirkpatrick
Dec 15, 2015·Expert Review of Clinical Pharmacology·Timothy M E DavisLaurens Manning
Sep 9, 2011·Expert Opinion on Drug Metabolism & Toxicology·Rita Piedade, José Pedro Gil
Nov 21, 2009·The Lancet Infectious Diseases·Reinhold KerbMatthias Schwab
Nov 7, 2009·Reproductive Toxicology·Kevin T BattyTimothy M E Davis
Nov 21, 2013·British Journal of Clinical Pharmacology·Kashyap PatelCarl M Kirkpatrick
Aug 28, 2009·Fundamental & Clinical Pharmacology·Kesara Na-Bangchang, Juntra Karbwang
Aug 19, 2015·Analytical and Bioanalytical Chemistry·Laura ZehnackerStéphane Azoulay
Aug 24, 2013·Journal of Parasitology Research·J N BoampongE Woode
Dec 17, 2014·Pharmacogenomics·Ar Kar AungElizabeth J Phillips
Oct 1, 2008·Current Opinion in Microbiology·J Carl Craft
May 30, 2014·The Cochrane Database of Systematic Reviews·Joseph Okebe, Michael Eisenhut
Sep 24, 2015·Antimicrobial Agents and Chemotherapy·Sunil ParikhKimberly K Scarsi
Aug 8, 2018·Antimicrobial Agents and Chemotherapy·Adebanjo AdegbolaOluseye Bolaji
Jan 18, 2017·Antimicrobial Agents and Chemotherapy·Leah A Walker, David J Sullivan
Nov 14, 2018·Antimicrobial Agents and Chemotherapy·Stephen I WalimbwaSaye H Khoo
Jun 20, 2017·The Annals of Pharmacotherapy·Alice TsengElizabeth J Phillips
Apr 16, 2010·International Journal of Technology Assessment in Health Care·Harriet NabudereMalick Juma
Nov 4, 2009·Expert Review of Anti-infective Therapy·Donald L GardinerKatharine R Trenholme

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.